The Nitrosamine puzzle: What We Learned in the Last Five Years

The Nitrosamine (NA) issue, often termed the “Saga,” has been a focal point of attention for both the pharmaceutical sector and regulatory entities over the past half-decade…

The Nitrosamine (NA) issue, often termed the “Saga,” has been a focal point of attention for both the pharmaceutical sector and regulatory entities over the past half-decade…